Over a decade after collective actions were introduced into Mexico’s legal framework, COFECE has filed its first action of this type against companies in the pharmaceutical sector. This action seeks compensation for damages to the public health system due to an alleged price-fixing cartel. By focusing on protecting the public’s diffuse rights, this lawsuit brings a new approach to economic competition enforcement and marks a potential turning point in collective litigation in Mexico.
This note examines the legal framework and procedural challenges COFECE faces in sanctioning anticompetitive practices, as well as the potential impact of this trend on companies operating in regulated sectors.
You can read the full content of the Legal Note here.